In another study, intravenous infusion of GLP-1 prior to, and during, a glucose challenge in patients with T2DM was associated with an insulinotropic effect on both first- and second-phase insulin secretion, augmentation of glucose disappearance rates, and suppression of circulating glucagon levels [36]. This evidence concerns the gene GCG and type 2 diabetes mellitus.